CERE
Cerevel Therapeutics Holdings, Inc.
CEO and Chair N Anthony Coles sold $1.4M of Cerevel Therapeutics Holdings, Inc.
Sold$1,355,947
$27.12Price
50,000Shares
−95%Stake
What CERE did after the filing
- The stock from Mon, Mar 6 close, $27.63
- −4.2%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Apr 18 close.
Traded Thu, Mar 2. Filed Mon, Mar 6, 11:15 AM ET, during the session. Returns use the Mar 6 close and the Apr 18 close. Not investment advice.